DURHAM - Slate Pharmaceuticals, a company specializing in hormone delivery products, has raised $5 million in an initial round of fundraising as it works to commercialize its first product - a small pellet that administers testosterone.
DURHAM - Slate Pharmaceuticals, a company specializing in hormone delivery products, has raised $5 million in an initial round of fundraising as it works to commercialize its first product - a small pellet that administers testosterone.
